CAMBRIDGE, Mass., Nov. 13, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Valo Health today announced that industry leader Brian M. Alexander, M.D., M.P.H. has been ...

Valo to leverage human causal biology expertise to uncover new insights about NOD2 as a potential Parkinson’s disease drug target LEXINGTON, Mass., September 09, 2025--(BUSINESS WIRE)--Valo Health, ...

Collaboration will apply Valo’s Opal Computational Platform™ and real-world patient dataset to enable the discovery and development of novel cardiometabolic drug programmes Novo Nordisk licenses three ...

Valo Health, Inc. (“Valo”), a biotechnology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence (AI), today announced the ...

The collaboration could expand to 'the entire drug discovery continuum', the two companies say. Novo Nordisk and Boston-based Valo Health, Inc. this week announced the launch of a collaboration that ...

Scope of collaboration originally signed in 2023 will significantly expand to enable the discovery and development of up to 20 novel drug programmes in obesity, type 2 diabetes, and cardiovascular ...

Valo Health, Inc. ("Valo"), a company pioneering the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Rita Kale as Chief Financial Officer (CFO ...

BOSTON, March 15, 2022 /PRNewswire/ -- Valo Health, LLC ("Valo"), the technology company built focused on transforming the drug discovery and development process using human-centric data and ...

Flagship Pioneering has lifted the lid on its latest biotech: Valo Health. The startup begins life with close to $100 million, Forma Therapeutics’ hit discovery capabilities and ambitions to shave ...

Valo and Khosla Ventures Acquisition Co. cited “current market conditions, particularly in the biotechnology area,” as the reason for calling off the deal, announced in June, which would have valued ...